Graph Therapeutics

The company utilizes a platform to capture the dynamic behavior of live patient immune cells to power drug discovery for inflammatory and immune-mediated diseases. It employs immune mapping and functional profiling to identify therapeutic targets in conditions such as rheumatoid arthritis and systemic inflammation. The technology focuses on decoding patient variation and front-loading clinical success through multiomics profiling.